ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,733.50
5.00 (0.29%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 0.29% 1,733.50 1,732.50 1,733.00 1,739.50 1,724.50 1,733.00 4,237,056 16:35:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.48 71.35B

ADRs End Lower

20/09/2017 10:39pm

Dow Jones News


Gsk (LSE:GSK)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Gsk Charts.
   By Imani Moise 
 

International stocks trading in New York closed mostly lower on Wednesday.

Diageo PLC (DEO) and GlaxoSmithKline PLC (GSK) were among the companies with ADRs that traded actively.

The BNY Mellon index of American depositary receipts fell 0.2% to 148.88. The European index decreased 0.2% to 138.47, the Asian index dropped 0.3% to 172.36, and the emerging markets index declined 0.4% to 324.01. The Latin American Index was the only indicator that rose, growing 0.4% to 259.28.

ADRs of Luxembourg-based steel maker ArcelorMittal SA (MT) fell 0.2% to $26.85 after Thyssenkrupp AG (TKA.XE) and Tata Steel Ltd (500470.BY) laid out plans to combine their European steel activities in a move that would create the region's second-largest steel producer.

ADRs of GlaxoSmithKline rose 0.7% to $40.18 after the drug company reported positive results in a late stage trial of Trelegy Ellipta, a triple-therapy inhaler for patients with chronic obstructive pulmonary disease.

ADRs of Diageo fell 2.8% to $131.71 after the drinks company, which houses Johnnie Walker, Crown Royal, J&B, Buchanan's and Smirnoff, said that it expects organic sales growth to be hit by the later timing of Chinese New Year.

ADRs of CEMEX SAB (CX) rose 2.3% to $9.34 after being upgraded by Standard & Poor's.

 

Write to Imani Moise at imani.moise@wsj.com

 

(END) Dow Jones Newswires

September 20, 2017 17:24 ET (21:24 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock